SCHEMBL22635896

SCHEMBL22635896

O=C(Nc1ccccc1)N1C2CCC1CNC2

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
POLB P06746 1/20 0.50
ELOVL6 Q9H5J4 4/20 0.49
HTT P42858 1/20 0.47
KDM4E B2RXH2 1/20 0.47
AGTR2 P50052 1/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TP53 P04637 1/20 0.46
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
JAK3 P52333 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
FAAH O00519 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20069833 0.90 ALDH1A1 (0.53) ALDH1A1MEN1KMT2APOLBELOVL6
SCHEMBL30359159 0.83 ALDH1A1 (0.56) ALDH1A1MEN1KMT2AKDM4ENPC1
SCHEMBL30359029 0.80 KDM4E (0.51) ALDH1A1MEN1KMT2AKDM4ENPC1
SCHEMBL29432699 0.79 PKM (0.55) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL22635910 0.78 NOX1 (0.43) ALDH1A1KMT2AHTTKDM4E
SCHEMBL30359063 0.78 KIF11 (0.47) ALDH1A1KMT2AELOVL6NPC1RAB9A
SCHEMBL25423269 0.77 USP2 (0.54) MEN1KMT2APOLBHTTKDM4E
SCHEMBL22635904 0.77 KCNK3 (0.42) MEN1KMT2AELOVL6HTTMAPT
SCHEMBL30359190 0.77 TSHR (0.57) ALDH1A1MEN1KMT2APOLBGAA
SCHEMBL30358995 0.75 L3MBTL1 (0.56) ALDH1A1SMN1; SMN2GAAMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020225185-A1 COMBINATION OF AN α2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA BAYER AKTIENGESELLSCHAFT (DE) 2020-11-12 WO disclosed